CELAVISTA MITO-BIOGENESIS

Logo Celavista Mito-Biogenesis

Contact information

CELAVISTA MITO-BIOGENESIS
Joan Puig Rigall, R&D Project Leader
Parque Científico de la UPV/EHU, Edificio SEDE, Sarriena Auzoa s/n
Leioa
Bizkaia
+34 689 13 43 18
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biological defense
      • Medical devices
      • Gene Therapy
    • Therapeutic areas
      • Dermatology
      • Musculoskeletal system
      • Infectious diseases
      • Gynaecology and obstetrics
      • Immunology
      • Ophtalmology and optometry
      • Blood and lymphatic system
      • Digestive system and hepatology
      • Kidney and genitourinary system
      • Respiratory and pulmonary system
      • Metabolic disorders / Endocrinology
  • B. Agrifood Biotechnology
    • Agriculture / veterinary / environmental
      • Environmental cleanup / testing
    • Food
      • Functional Food
  • C. Industrial Biotechnology
    • APIs and green chemistry
    • Waste valorisation
  • MISSION. R+D+i in Biomedical Sciences (medicines, food supplements, biomaterials, functional foods, etc.) based on a new science, NATUREMIMETICS (inspirated in Nature research + human knowledge + innovation-technology + sustainability + values).
  • VISION. Offer a new concept of biomedical products, called EPIMIMÉTICOS, eco-designed, eco-efficient, sustainable products that seek to improve the health and life quality of humans and animals, protecting and respecting their environment. These products will be our hallmarks.
Products and services
  • Areas of Activity
    • Pharma (medicines, food supplements)
    • Biomaterials
    • Functional Foods
    • Precision Biomedicine
    • Tissue Engineering / Robotics
  • Therapeutic Areas
    • Obstetrics and Gynecology. Human Reproduction
    • Urology and Andrology
    • Ophthalmology
    • Immunology
    • Inflammatory Diseases
    • Aging and Deterioration Prevention
  • Services
    • R&D&i for third parties (food supplements, functional foods, drugs, biomaterials)
    • Precision Medicine

 

Areas of interest for future collaborations
  • Pharmaceutical and Biotechnology Industry (development of food supplements, drugs, tissue engineering, etc.)
  • Food Industry (functional foods)
  • Industry in general and health area (biomaterials)
  • Research centers
  • Health providers, medical centers, diagnostics, therapeutic technology, etc.
     

Biotech Sanitaria

Drugs Multinational Subsidiaries
Product / Service Type Therapeutic area Development phase
Retriacyl Biodrugs/ Drugs Oftalmología y optometría P III

Biotech Agroalimentaria

Ingredients, additives and probiotics
Product / Service Aplication Development phase
NMX-MgBi Chronic, acute and advanced renal failure. Prevention and improvement of renal function with age. Development of pharmaceutical and food formulations Registration
Veterinary Drugs
Product / Service Therapeutic area Development phase
NMX-ITU-VET Enfermedades infecciosas Preclinical

Biotech Industrial

Bioproduct
Product / Service Development phase
NMX-FixCo2 R&D
Bioprocess
Product / Service Development phase
NMX-FixCo2 R&D
Other Technologies
Product / Service Development phase
NMX-FCD Ready for explotation